☰
According to reliable sources, U.S.-based privately held biomedical organization AltPep Corporation has raised a total of USD 23.150 million in a Series A investment round. The funding was led by Boston-based private i...
With new digital equipment sprouting up in the medical sector, the global electrophysiology industry is witnessing a breakneck innovation in the past several years. Perhaps one of the most compelling trends to come out...
In recent developments, California-headquartered healthcare and social service provider WelbeHealth LLC has announced its plans to unite PACE programs, namely LA Coast PACE, Pacific PACE, and Stockton PACE under one ro...
In an effort to contain the spread of newly detected U.K. variant of coronavirus, South Korean authorities have reportedly planned to expedite the efforts to launch public vaccination program. ...
The US FDA (Food and Drug Administration) is reportedly investigating about five cases of individuals having allergic reactions to BioNTech and Pfizer’s COVID-19 vaccine. Post...
In recent developments, Syros Pharmaceuticals, Inc, a Cambridge-headquartered biopharmaceutical organization that focuses on developing treatments for immune-related diseases as well as cancer, has reportedly acquired ...
AstraZeneca and Oxford University have recently encountered a manufacturing error of their experimental COVID-19 vaccine, giving rise to questions about the preliminary trial results. ...
The U.S. FDA has recently issued an EUA (emergency use authorization) of casirivimab & imdevimab. These monoclonal antibodies will be jointly administered to treat mild to moderate COVID-19 disease among adults as ...
Male Contraceptive Initiative (MCI) announced its partnership with Contraline, Inc., a medical device company to provide a $1 million Program Related Investment (PRI) to back the first-in-human clinical test for ADAM&t...
Biological E. Limited, an India-based vaccines and pharmaceutical company, has reportedly started phase I and II clinical trials of COVID-19 sub-unit vaccine candidate after getting the Drugs Controller General of Indi...
Five Prime Therapeutics, Inc. has recently revealed the 1st pre-clinical data of the anti-CCR8 FPA157 program. The pre-clinical results were presented at the SITC (Society for Immunotherapy of Cancer)’...
Clinical stage biopharmaceutical major, Liminal Biosciences Inc., has reportedly announced the extension of its Ryplazim BLA (Biologics License Application) by the U.S. Food and Drug Administration for the treatment of...
NanOlogy LLC, a renowned clinical-stage oncology firm working on intratumoral therapy for solid tumors, has reportedly enrolled the very first patient for its Phase 2 clinical study of NanoPac, its intratumoral injecti...
Imugene Ltd., a biotechnology firm that specializes in cancer immunotherapy, has recently bagged an investigational new drug (IND) approval from the US Food and Drug Administration (FDA) to commence the Phase-1 clinica...
Ampio Pharmaceuticals Inc., the U.S-based biopharmaceutical firm focused on the development of novel therapies aimed at treating common inflammatory conditions, has reportedly commenced recruiting and enrolling patient...
Syros Pharmaceuticals has announced initial safety, pharmacodynamics (PD) and pharmacokinetics (PK) data from the current dose-escalation portion of Phase 1 clinical trial of SY-5609 in patients with select solid tumor...
ImmunityBio, a privately held immunotherapy firm, and NantKwest, a clinical-stage immunotherapy organization that develops immunotherapeutic treatments for viral infectious diseases and cancer in the US, announced that...
ICT International, a renowned medical testing device manufacturer, is reportedly launching new rapid antigen testing in the industry, a complete game-changer when it comes to the global pandemic. Having a test that det...
Summa Equity, a Sweden-based thematic investment firm that invests in enterprises that address global challenges, has reportedly purchased a majority stake of functional proteomics firm, Sengenics, who possesses a prop...
MedAlliance, a medical technology company, has reportedly announced the enrollment of the 1st two patients in the Prospective Registry, PRISTINE, with SELUTION SLR™ 018 DEB. The PRISTINE trial will be conducted a...
Eureka Therapeutics Inc., a biotechnology firm that focuses on immunotherapies for the treatment of cancer, has reportedly commenced an ARYA-1 clinical trial to evaluate ET140203 ARTEMIS® T cell therapy in adult pa...
MGC Pharmaceuticals, a renowned EU based bio-pharmaceutical firm, has reportedly announced that it has expanded the double-blind, placebo-controlled phase II clinical trial that assesses the efficacy and safety of its ...
Accenture, a renowned professional services company, has reportedly announced that it developed a data and analytics approach to derive and manage insights from the genomic data of pediatric AML (acute myeloid leukemia...
Swiss-based multinational pharmaceutical company, Novartis has recently revealed detailed results from the Phase III COMBI-i study assessing spartalizumab (PDR001), the investigational biological therapy in combination with Mekinist® (tra...
Biopharmaceutical major, Curevo Vaccine, has reportedly announced the release of antibody response data from its completed Phase 1 study that carried out the investigation of CRV-101’s tolerability, safety, and i...
According to reliable sources, Spain is planning to host the phase 2 clinical trials of the US-based pharmaceutical company Johnson & Johnson’s COVID-19 vaccine by mid-September 2020. ...
Clinical life science and technology solutions provider, Bioclinica, has reportedly entered into an agreement with regenerative products manufacturer, Direct Biologics. The partnership intends to deploy the Interactive...
The Government of Australia has announced its intent to purchase more than 84 million doses of potential coronavirus vaccines on a condition that they succeed clinical trials. The is vaccine is planned to be purchased ...
Novartis, a renowned Swiss pharmaceutical company, has reportedly released Phase II data of its investigational oral therapy for PNH (paroxysmal nocturnal hemoglobinuria), LNP023, at the 2020 EBMT (European Society for...
Slated as a significant health issue, postoperative nausea and vomiting (PONV) has impacted the lives of numerous patients that undergo surgery in the U.S. According to a report, PONV, upon not being treated, can occur...
Dutch vaccine developer, Intravacc, has reportedly announced that the Phase I clinical trial of its Respiratory Syncytial Virus vaccine candidate has given positive results. The candidate was observed for triggering im...
While the world's foremost companies are coming up with a vaccine for the novel coronavirus, Lunit Inc, a South Korean medical imaging startup, has reportedly introduced a new testing method to detect the presence ...
A laser therapy conducted at the Massachusetts Hospital has recently shown positive results for treating a patent suffering from COVID-19. The study led by Dr. Scott Sigman showed that the patient, following a Pho...
Claro Brazil has reportedly announced that it has joined forces with Ericsson to deliver the first 5G network in Latin American with the help of Ericsson’s dynamic spectrum sharing technology. Claro has planned t...
Innovent Biologics, Inc., the China-based biopharmaceutical company, has reportedly announced that it has dosed the first patients in its Phase 1 clinical trial to assess IBI322 (Anti-CD47/PD-L1 Bispecific Antibody) in...
This trial will evaluate RP-3500 both as a monotherapy and in combination with talazoparib, Pfizer’s PARP inhibitor. Repare Therapeutics Inc., a Canada-based ...
Moderna Inc, the American biotechnology company with expertise in vaccine technologies based exclusively on mRNA, has reportedly received an additional USD 472 million funding from the BARDA (Biomedical Advanced Resear...
Medidata, a division of Dassault Systèmes, has recently revealed that it is partnering with Moderna, Inc. to support clinical studies of the pharma giant’s COVID-19 vaccine candidate, mRNA-1273. As per rep...
Amplyx Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing small molecules drugs, has reportedly announced the positive top-line outcomes from its Phase 2 clinical trial of fosmanogepix. ...
A group of researchers from the University of Minnesota have recently conducted a new groundbreaking study where they 3D printed a fully operational centimeter-scale human heart pump, a discovery that could augment the...
JS016 is apparently unique to the SARS-CoV-2 surface spike protein receptor-binding domain. JS016 can block virus ...
Smiths Detection, a global leader in security screening technologies, has recently revealed that it has joined forces with multiplex blood-testing technology firm, Attomarker Ltd. The partnership focuses on developing ...
Sinovac Biotech Limited has recently obtained an approval from Anvisa, the Brazilian Health Regulatory Agency, for the Phase 3 clinical trial of the COVID-19 vaccine. This clinical ...
Transcenta Holding Limited, a biotherapeutics firm based in Shanghai that focuses on discovering, developing and commercializing antibody-based therapeutics, has recently revealed dosing its first candidate in the US P...
A recent study published by the Journal of Clinical Oncology suggests carboplatin-paclitaxel as a standard of care for anal cancer. According to the study, inoperable anal cancer, when treated with carboplatin-paclitax...
Tandem Diabetes Care, Inc., a San Diego-based diabetes technology and insulin delivery company, has recently announced that it has acquired Sugarmate, a prominent mobile app used by diabetes patients that require insul...
Regenerative medicine firm Rexgenero has confirmed that it has acquired key technology and assets from Paris based preclinical-stage immunotherapy biotech company, aratinga.bio SAS Group. Rexgenero is known for develop...
Lucknow-based Central Drug Research Institute, a constituent lab of the Council of Scientific and Industrial Research, has been reportedly approved to conduct Phase III trials for the deployment of Umifenovir drug agai...
A leader in aesthetics markets, Bimini Health Tech recently announced it has acquired California-based Healeon Medical, Inc., that is focused on paving the way for regenerative solutions by providing support for point-...
OncoImmune, a pharmaceutical company engaged in making immunotherapies for cancer, autoimmune diseases, and inflammation, has reportedly announced that it has reached a crucial milestone in Phase 3 clinical study that ...
Chr. Hansen Holding A/S, based in Denmark, focused on developing natural solutions for the nutritional, beverage, food, agricultural and pharmaceutical industries recently announced plans to acquire UAS Labor...
The race to develop an effective treatment for cancer has seen several partnerships and mergers among healthcare companies. Recently, UK-based biopharmaceutical corporation, AstraZeneca Plc took a similar approach...
Matt Clark, Senior VP of Chemistry and X-Chem Co-Founder, would be named as the new company CEO London-based healthcare investment adviser, Global Healthcare Opport...
Innovent Biologics, Inc. and Eli Lilly and Company have jointly announced the results of the pivotal clinical trial, TYVYT® ORIENT-2 study. This clinical trial is the study of the 2nd-line treatment for the metasta...
The cannabis based drug has previously been used for epilepsy treatment and this study is being conducted in babies as part of a research to prevent seizures which can lead to brain damage....
Selvax Pty Ltd, the Australian cancer immunology group engaged in developing immunology based treatments for large solid tumors, has reportedly announced positive results from its immunotherapy treatment in 10 dogs bat...
Curative Inc., a COVID-19 testing startup, has recently completed the acquisition of a DEA licensed and CLIA certified analytical laboratory, KorvaLabs, Inc. The deal happened along...
As the effects of coronavirus intensify, countries all over the world have started to implement measures to develop a vaccine that could minimize the loss arising from this crisis. The UK recently made a development to...
The DNA Company, a renowned functional genomics provider, has reportedly announced that it has acquired MPS (My Pain Sensei), an AI-based digital therapeutics app, for a total amount of about $30M, forming My Next Heal...
RXVIP Concierge, a leading enterprise that focuses on improving the role of Pharmacists in the field of healthcare, has reportedly unveiled its first telehealth and remote patient monitoring residency program as well a...
Orexo, a renowned Sweden based pharmaceutical company, has reportedly announced that it acquired the exclusive rights to commercialize GAIA AG’s digital therapy solution, deprexis®, in the U.S. Deprexis is a ...
NAPA (North American Partners in Anesthesia), a leading single-specialty anesthesia management company, and MEDNAX, Inc., a US-based clinical company delivering advanced medical solutions, reportedly announced NAPA&rsq...
Orbis will help to improve the Pharmaceutical Technologies occupation of Adare Its platforms generally develop drug particles dosed ...
Roche Holding AG, a multinational healthcare company, has recently been issued test with an EUA (Emergency Use Authorization) for its new Elecsys® Anti-SARS-CoV-2 antibody. This antibody test was designed to examin...
Amidst various companies relentlessly conducting trials of potential COVID-19 treatment drugs across various geographies of the world, Glenmark Pharmaceuticals Ltd., reportedly announced that it would start clinical tr...
Trovagene Inc., a clinical-stage oncology therapeutics firm involved in the development of drugs for treating cancers with considerable medical needs for novel therapeutic options, like leukemia, colorectal cancer and ...
NEC Corporation, a Japanese multinational electronics and information technology company, has recently revealed analysis results from its ongoing efforts of employing AI prediction platforms for designing blueprints fo...
The Lebanese parliament has recently passed a legislation that legalizes the cultivation of cannabis for both industrial and medical purposes. This move had been originally recommended by various economic advisors much...
Kevin Systrom along with Mike Krieger, the founders of Instagram, have come together to unveil their first product after having left the Facebook group. They have introduced a tracker called Rt.live which is a tool pro...
The companies are using a proprietary technology to track specific conversations regarding COVID-19 The transaction marks W2O’...
The study aims at analyzing the tolerability and safety of ATG-019 monotherapy or in combination with niacin ER Antengene is also exploring the pot...
The medical technology company has received Breakthrough Device Designation by the FDA for its Oxygen Assist Module (OAM). The OAM module is common...
Polaryx Therapeutics, Inc., a developer of drug candidates for lysosomal storage disorders, has recently gained IND (Investigational New Drug Application) approval from the U.S. FDA. This approval is related to the stu...
Another potential COVID-19 vaccine has recently received FDA approval to commence clinical trials among humans. The vaccine, developed by Inovio Pharmaceuticals and backed by Melinda and Bill Gates, is the second such ...
LSU Health, a renowned public university focused on health sciences, has now reportedly become one of the first centers of the U.S. to start the enrollment of coronavirus patients in a global trial to test the use of n...
Evotec gains access to panCELLa’s iPS cell lines known as- iACT Stealth Cells™ The company will also gain control over FailSafe™...
nference, an augmented intelligence-based biomedical company, reportedly unveiled a software resource that is capable of synthesizing disparate scRNA-seq (Single Cell RNA-sequencing) datasets to fight the coronavirus p...
From developed countries to emerging economies, people across the globe are demanding for protective masks to reduce the risk of getting infected by COVID-19. To cope up with increasing demand, Battelle Memorial Instit...
Nexstim Plc, a Finland-based medical technology company recently announced to have bagged two new NBS (Navigated Brain Stimulation) System orders from two leading medical institutions in the U.S. ...
Alike many organizations across the globe that have come forward to help healthcare workers and front-line responders to fight this global pandemic, Merck & Co., Inc., an American multinational pharmaceutical compa...
Amazon.com is reportedly teaming up with a Bill Gates-funded research program to offer pickup and delivery services of coronavirus testing kits in Seattle. The SCAN (Seattle Coronav...
The UK government has recently approached Amazon and some other companies to use their services to accelerate the urgent delivery of coronavirus tests to healthcare facilities and social care workers. ...
In a bid to fight against harmful bacteria, Felix, a U.S.-based biotech firm, has recently decided to devise a programmable virus that kills chronic bacteria. Reportedly, farmers and doctors overuse antibiotics to erad...
As nations across the globe continue to grapple with the novel COVID-19 outbreak, several institutes are trying come up with a vaccine to tackle this global pandemic. The Milken Institute, a non-profit t...
The testing kits will be available with public health providers, hospitals and other medical institutions based in the U.S. CoronaCheck ™ was...
Scientists from Oxford University have reportedly created a technology to accelerate the testing for COVID-19. The test is validated at China’s Shenzen Luohou People’s Hospital with real clinical samples. I...
While the coronavirus manages to spread across major global economics, scientists and researchers all over the world are plowing their way to find a definite cure for this current pandemic. ...
Verizon has announced to support communities by contributing $10 million to provide relief services for people impacted by the ongoing coronavirus (COVID-19) pandemic. The company has tripled its monthly data allowance...
Respiratory syncytial virus (RSV) is a seasonal virus infection that can cause severe lower respiratory infection The vaccine candida...
Spero Therapeutics, Inc., a renowned Massachusetts-based clinical-stage, multi-asset biopharmaceutical company, has reportedly announced that the United States Food and Drug Administration has granted its oral drug SPR...
The IPH5201 Phase I clinical trial is backed by positive pre-clinical results shown at the SITC AstraZeneca, the company’s partner, is the sp...
Leronlimab can reduce the mortality rate in patients with moderate to severe cases of coronavirus Patients will be treated with leron...
Royalty Pharma, one of the leading companies engaged in acquiring pharmaceutical royalties, has reportedly acquired royalties on Entyvio®(vedolizumab) from Massachusetts General Hospital (MGH) for USD 94 million....
The biopharmaceutical company completes enrollment for Phase 1/2 clinical study of IDCT to treat patients with degenerative disc disease A clinical stage biopharmac...
Pivotal, a full-service contract research organization (CRO), has reportedly acquired Akcelis BVBA, one of the leading players in patient recruitment, engagement, and retention, to offer its existing and future clients...
Neuraly has claimed that it has dosed the first patient of NLY01 in its Phase 2 study for Parkinson’s disease. Nature Medicine claimed in its study that NLYO1 tends to bind up...
PAVmed Inc. has recently announced that Lucid Diagnostics has entered an agreement with UPenn (University of Pennsylvania) to perform clinical trial research for its EsoCheck device. Lucid Diagnostics is a subsidiary o...
Khiron Life Sciences Corp., a vertically integrated cannabis company, has recently obtained manufacturing quotas for high-THC medical cannabis from the TQG (Colombian Technical Quotas Group). The manufacturing quotas w...
Altasciences Company, Inc., a clinical research organization specializing in end to end drug development, has reportedly announced the acquisition of U.S based pharmaceutical company, Alliance Contract Pharma....
Ascentage Pharma, a clinical-stage biotechnology firm developing innovative therapies for cancers, has reportedly received approval for its Phase Ib/II clinical trial from the CDE (Center of Drug Evaluation), China NMP...
Burgeoning numbers of coronavirus cases have encouraged researchers to develop a viable vaccine candidate. Clover Biopharmaceuticals, a Chinese clinical-stage biotechnology company developing transformative and novel b...
Kadmon, a clinical-stage biopharmaceutical company, has reportedly announced expanded results from the earlier reported short-term analysis of ROCKstar (KD025-213), the company’s ongoing crucial trial of KD025 in chronic GVHD (graft-versus-h...
VBL Therapeutics, a renowned Israeli biopharmaceutical company, reportedly announced the initiation of phase 2 clinical study of VB-111 combined with immune checkpoint inhibitor, nivolumab (Opdivo®). This study wou...
Advaxis, Inc., a clinical-stage biotechnology company developing and commercializing immunotherapy products, has reportedly announced positive outcomes from the monotherapy and combination arms of its in progress Phase...
Matinas BioPharma, a renowned biopharmaceutical company, has reportedly announced that DSMB (Data Safety Monitoring Board) for the EnACT study has finished its planned review of initial tolerability and safety data from the Part 1 dose escalation ...
MB-106 has been developed for cancer in partnership with Fred Hutchinson Cancer Research Center Phase 1/2 clinical trial is assessin...
The U.S. FDA (Food and Drug Administration) has reportedly approved three drugs as an over-the-counter product; GlaxoSmithKline's Voltaren Arthritis Pain and Alcon’s two allergy-related drugs. As per sources,...
Bristol-Myers demonstrates five year follow up results from CheckMate-25 Phase 3 study for Opdivo in patients with formerly treated advanced or metastatic RCC ...
Pulse Biosciences, Inc., an innovative bioelectric medicine company committed to improving the lives of patients, has reportedly announced an update on its U.S. FDA ( Food and Drug Administration) submission for the Ce...
Abeona Therapeutics Inc., a leading biopharmaceutical firm focusing on cell and gene therapy, has recently revealed that Abigail Wexner Research Institute’s (AWRI) researchers from Nationwide Children’s Hos...
Japanese multinational pharmaceutical company, Astellas Pharma Inc. and U.S-based Pfizer Inc. have reportedly announced results of final OS (overall survival) analysis from the Phase 3 PROSPER clinical trial, which ass...
KSQ Therapeutics has propelled their effort to derail refractor solid tumors by growing —eTIL™—engineered tumor infiltrating lymphocyte therapies by announcing the identification and validation of CT-...
Anteros will focus on developing new class drugs for inflammatory diseases This is the first firm launched by the companies under their Strategic P...
American health insurer, Humana Inc. and private equity firm WCAS (Welsh, Carson, Anderson & Stowe) have reportedly formed a joint venture to develop senior-focused primary care centers. Reportedly, ...
The data from the REMETY phase 1 dose escalation trial, unveiled at the Gastrointestinal Cancers Symposium 2020, reportedly shows that the combination of regorafenib (Stivarga) and oral fluoropyrimidine TAS-102 provide...
· Tazverik received accelerated approval, that allows FDA to permit medication for serious ailments ·&...
The tour aims at raising awareness regarding the importance of annual eye checkups It will first kick start in North Carolina this week bef...
Moderna, Inc., a Cambridge, Massachusetts-based biotechnology firm that is focused on drug discovery and development based on mRNA, has announced entering into a new autoimmune therapeutic area. Being built on the clin...
Survival rate for stage II colon cancer is about 58 to 88% and patients will gain from additional treatments Guardant Health, Inc., a renowned precision oncology fi...
Revolution Medicines, a renowned American biopharmaceutical company working towards discovering new solutions for cancer, reportedly announced that it would be unveiling preliminary data collected from its Phase 1 clin...
Acura Pharmaceuticals has issued an update pertaining to the evolution of the much-anticipated LTX-03 tablets using technology called Acura LIMITx™ meant to curb risks linked with overdose of hydrocodone. Apparen...
The company contemplates NDA filing in the second half of 2020 Top-line results exhibited statistically exceptional improvement on a...
Sacituzumab govitecan has attained both Breakthrough Therapy Designation and Fast Track Designation by the FDA. Immunomedics, Inc., a biopharmaceutical firm, has re...
Fibrotic diseases are commonly termed as chronic tissue injury. Renal fibrosis, hepatic cirrhosis and pulmonary fibrosis are some of the common fibrotic diseases. Currently, these diseases have limited treatm...
The study will compare safety, tolerability, and pharmacokinetics with reference products in Europe Subjects involved in the trial w...
Puma Biotechnology will enroll more patients to obtain additional data to support the approval of combination therapy for metastatic breast cancer ...
Xeris Pharmaceuticals, Inc., a specialty biotechnology firm that commercializes and develops ready-to-use (RTU) infusible and injectable drug formulations, has recently revealed topline results from its in-clinic stage...
Karyopharm Therapeutics, a renowned pharmaceutical firm focused on the development, discovery, and commercialization of new therapies to treat cancer and other major diseases, reportedly announced that four posters per...
The data was presented at the annual meeting of American Epilepsy Society (AES) held in Baltimore Stokes will apply for investigation...
The reward will accelerate the development of VE707 for various multi-drug resistant infections Vedanta Biosciences is eligible for a...
Atomwise Inc., a U.S.-based AI system developer has recently formed a joint venture (JV) with biotech company, StemoniX Inc. to merge its AI technology with StemoniX's human microOrgan® platform. Sources close the move suggest that this wo...
FDA grants approval for Genentech’s Tecentriq – Chemotherapy combination treatment, based on positive results from Phase III Impower130 trial...
This would be the first registered immune checkpoint inhibitor for treating PD-L1-positive TNBC in Japan. The drug has also been list...
The two firms would focus on analyzing and testing the clinical biopsy tissue samples from subjects participating in the Phase 3 Atalante 1 clinical study, currently under progress. ...
Seattle Genetics, a biotechnology company focused on innovating novel therapies for cancer, has recently attained approval from Health Canada for supplemental New Drug Submission that expands the use of ADCETRIS (brent...
The data was presented at the Society for Neuro-Oncology (SNO) Annual Meeting 2019, held in Phoenix. With the use of controlled ...
The company will present a study of neoadjuvant and adjuvant VB-111 for treatment of recurrent GBM. The ongoing trial aims to explore the potential...
Givlaari is the second-ever drug from Alnylam to get approval from the FDA People with severe abdominal...
Data renders evidence of clinically improved outcome in recurrent pericarditis Results were presented at the American Heart Association (...
Shionogi & Co., Ltd., a Japan-based pharmaceutical company recently announced approval of drug cefiderocol (FETROJA®) by the U.S. Food and Drug Administration. The drug can now be used for the treatment of comp...
NEC Corporation, a leading firm in network technologies and IT, and VAXIMM AG, a biotech firm focused on the development of oral T-cell immunotherapies, recently announced that both the companies inked a strategic agre...
The companies unveiled safety and efficacy results for filgotinib in numerous RA patients This data will be presented at the annual 2...
The study would deliver crucial data that could help PredictImmune validate PredictSURE IBDTM in diverse patient populations. PredictImmune has made its name by dev...
Risk assessment in lung cancer has become a vital factor for patients with newly diagnosed nodules. Around 3 out of 4 patients are characterized with low to moderate nodules, for which there are no ...
NOXXON Pharma, a renowned biopharmaceutical firm based in Germany that is focused at enhancing cancer treatment by aiming at the TME (tumor microenvironment), reportedly announced the enrollment as well as treatment of...
Artificial Intelligence in healthcare industry is set to be one of the highest revenues generating markets in the future due to the extraordinary benefits offered by this integrated system to the patients. Thus, collab...
Alopecia areata, an autoimmune disease that causes hair loss is seen to grow substantially and higher number of people every year. Global pharmaceutical firms are increasingly working towards development of medicines f...
Driven by the need for better customer experience, the healthcare sector is experiencing a huge shift towards digitalization. Today, organizations across the globe are increasing their invest in healthcare software off...
There is a rise in the number and spread of rare disorders. Due to their growing presence and risk, various pharmaceutical firms are increasingly working towards the discovery and development of treatments. ...
Drugs used for the treatment of various diseases are only made available in the market after confirmation of its safety and efficacy in patients enrolled in its clinical trials. Clinical studies indicate possibility of...
There is a substantial growth in the number of inflammatory and autoimmune diseases cases. Various firms across the world are increasingly working towards the development and discovery of drugs that can effectively tre...
Corporate mergers and acquisitions in the pharmaceutical sector are considered a vital part of an organizational growth strategy. It opens many opportunities that help companies carry out reduction in business risk, co...
Amyotrophic Lateral Sclerosis (ALS) is a progressive fatal neurodegenerative disease which causes low functionality in lower and upper motor nerves that control muscle function. It causes muscle weakness, paralysis, br...
With each passing day, new technologies are enabling researchers to develop therapeutic drugs that can help aid mankind. Because of innovative technologies and research, there is an availability for treatments targetin...
The Phase 2 study will register approx. twelve patients diagnosed with malignant mesothelioma that have failed systemic platin-based front-line chemotherapy. ...
The announcement resulted in a sudden surge of Lexicon’s shares, which went up by 37.8% to $2.37 in after-hours trading. France-based multinational pharma con...
The results from the Phase II/III trials, which involved efficacy data and preliminary safety, was presented at the IASLC 2019 World Conference on Lung Cancer, held in Barcelona, Spain. ...
The company is set to initiate a Phase 2 clinical trial in the U.S. after a successful Phase 1 trial in Spain. Rocket Pharmaceuticals, Inc., a U.S.-based biotechnol...
The biopharma company is planning to initiate the Phase 1/2 clinical trial of ADC cancer therapy that targets AKR1C3 and the Globo series. OBI Pharma, Inc., a ...
The German pharma company aims to initiate its phase II trial for BI456906 in late 2019, paying a sum of €20 million to Zealand Pharma A/S. Boehringer Ingelhei...
Xenleta (lefamulin) will be given Priority Review by FDA to act over its application in a quicker time frame. The Food and Drug Admin...
The approval includes an indication for pediatric patients over 12 years of age with NTRK-fusion-positive tumors based on information obtained primarily in adults. ...
The agency has already directed number of firms operating in the tobacco area to remove some of their products from the market. The U.S. Food and Drug Administratio...
Under the phase 2 trial approximately 90 patients with CLL will receive either ibrutinib or ibrutinib coupled with cirmtuzumab Oncternal Therapeutics, a biotechnolo...
This test would give opportunity to understand if NPS can induce immune response in patients with DCIS. The VADIS outputs could tell the company ab...
The Phase 1/2 study is a clinical trial of ET140202 ARTEMIS™ T-Cell therapy for the treatment of progressive hepatocellular carcinoma (HCC), one of the major types of liver cancer. ...
· Outputs would be shared globally with healthcare authorities at the next medical meeting. · While encouraging survival results were observed...
CEO Dr. Athena Countouriotis will participate in a question and answer session at the conference in Boston this month. Turning Point Therapeutics, Inc., a clin...
MRT5005 has been designed to address the primary cause of cystic fibrosis (CF) irrespective of genetic mutation Reports confirm that Translate Bio, an mRNA therapeu...
Novartis International AG, a Swiss-based pharmaceutical company recently announced results from Phase 3 PARAGON-HF trial in HFpEF (heart failure patients with preserved ejection fraction), investigating the efficacy &a...
The court has allowed 10X Genomics to sell products for use with already sold systems, subject to royalty payment. Bio-Rad Laboratories Inc., a manufacturer of clin...
The clinical study is expected to enroll about 18-30 cancer patients for testing. The clinical trial is expected to take approximately two years to complete. KAZIA Therapeutics Ltd....
The phase 3 study of arimoclomol for ALS is a 76-week, placebo-controlled, randomized study being conducted at 30 centers of excellence in Europe and North America. ...
Skyhawk Therapeutics, Inc., a drug discovery and development company, has recently announced that it has entered into an agreement with Genentech, a Roche Group member, to commercialize and develop small molecules that...
The global pharmaceutical giant Cipla reportedly announced that it has reentered Chinese market in an alliance with Jiangsu Acebright. The company will set up a manufacturing plant for respiratory products in China und...
Gilead will gain exclusive access to all of the existing and upcoming compounds in Galapagos’ pipeline Foster City, California-headquartered drug maker Gilead...
Pulmatrix, Inc. has reportedly activated three sites in the United States for the phase-2 clinical trial of Pulmazole (PUR1900). It is an inhaled formulation consisting of itraconazole for treating allergic bronchopulm...
In a recent turn of events, Dermata Therapeutics, a development-stage biotechnology company, has announced positive outcomes from Phase I proof of concept clinical trial of DMT410 (which is a combination of DMT310 and ...
OntarioMD, a company specializing in the selection, implementation and adoption of electronic medical records (EMR) and provincial digital health tools, recently announced that it will be adding 12 hospitals in north w...
AM-201 is an investigating drug being developed for the prevention of antipsychotic drug induced weight gain and somnolence. Auris Medical Ltd. – a ...
Hemostemix Inc., a Canada-based biotechnology company recently announced that its CLI (critical limb ischemia) trial abstract has been accepted to be presented at the 41st Annual Meeting of Canadian Society for Va...
Calysta, a biotechnology company recently announced that venture capital firm, BP Ventures invested $30 million to support rollout of Calysta’s FeedKind® protein, which is expected to improve global...
The trial is a significant milestone for the company as it advances a second mRNA therapeutic targeting a genetic disease into clinical development Translate Bio, a...
The pharmaceutical company received Regenerative Medicine Advanced Therapy designation from FDA for KB103 Krystal Biotech, Inc., a gene therapy company recently ann...
Dr. Reddy’s Laboratories Ltd., an India-based multinational pharmaceutical company, recently announced the launch of a therapeutic equivalent generic version of Phytonadione (Vitamin K1), Phytonadione Inject...
The trial’s interim results met the expectations of the primary endpoints that include safety, tolerability and PK Clinical-stage biotech company, DiaMedica T...
Celyad, a biopharmaceutical company focused on the advancement of CAR-T cell therapies, has confirmed updated clinical data for the CYAD-01 program in r/r AML and MDS, presented through a poster presentation session on...
The Phase 1b/2 clinical trial assessed the efficacies of vecabrutinib in patients suffering from CLL & other B-Cell related malignancies. The p...
The company expects to generate more than $300 million in sales by 2020 Endonovo Therapeutics, a commercial-stage developer of non-invasive medical devices that are...
Concert Pharmaceuticals, Inc., a clinical biopharmaceutical company, reportedly announced positive outcomes from two studies in its Phase 1 program assessing the effects of CTP-692, a novel deuterium-modified form of D...
Data to be presented at the European Congress of Rheumatology will confirm the efficacy and safety of the anti-TNF biosimilars and high adherence of patients who are being treated ...
The next-gen system is designed to automate correction boluses delivery when a user experiences, or is likely to experience, prolonged high glucose levels. Renowned...
Goldfinch Bio, Inc., a biotechnology firm developing precision therapies for kidney disease patients, has reportedly started dosing in its Phase 1 clinical trial assessing GFB-887. The firm’s selective and sub-ty...
· A patient participating in the clinical trial has already been dosed with the company’s lead candidate, leriglitazone. · The patient was given the dose at Hosp...
The companies will look to develop and optimize microflow LC-MS solutions which could advance the understanding and diagnosis of complex diseases Leading biotechnol...
The outcome of the Phase 1 ZUMA-3 study was presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. The re...
Reata Pharmaceuticals, a clinical-stage biopharmaceutical company recently announced enrollment of first patient in the Phase 3 FALCON trial of bardoxolone in patients with ADPKD (autosomal dominant polycystic kidney d...
The company expects enrollment of Phase I Trial during the third quarter of 2019. U.S. biotechnology firm, BioTheryX, Inc. has recently announced that the the ...
BioMarin Pharmaceutical Inc.’s experimental gene therapy, valoctocogene roxaparvovec, targeting severe hemophilia A in adults has reportedly met pre-specified clinical criteria to seek regulatory review in the U....
The trials were set to determine the Reprieve-Guided Diuretic Therapy system’s ability to achieve safe net volume reduction while alleviating related symptoms in ADHF patients. ...
It has reached the enrollment target of 30-35 patients that was determined when the OPTION study was started in December 2018 AzurRx BioPharma has recently confirme...
Pharmaceutical major Eli Lilly has officially launched an inexpensive generic version of the insulin drug Humalog, reports of which made way to the headlines in March. If sources are to be believed, the launch has come...
The trial is being conducted in patients with recurrent high-grade glioma An Independent Data Monitoring Committee recommended the study continue without mo...
The FDA approval was awarded to Solifenacin Succinate tablets’ abbreviated new drug application (ANDA). The pharmaceutical firm now holds a t...
177Lu-PSMA-617 is an experimental radiopharmaceutical which comprises of a peptide. The clinical-stage drug development company Noxopharm has reportedly ...
QIAGEN has been bringing its extensive track record of commercially creating and marketing novel diagnostic tests to the collaboration. QIAGEN N.V. and Inovio ...
Both the companies would reportedly merge the administrative, operational, and corporate management services under the brand name Cambia Health Solutions Insurance ...
The cancer immunotherapy drug could significantly reduce the risk of disease worsening or death (PFS) in patients by 40%. Swiss healthcare conglomerate, Roche AG ha...
ASLAN would grant BioGenetics exclusive rights for commercializing ASLAN003 in South Korea The therapy showed early signs of efficacy and safety in...
Suven has entered the asset purchase agreement through its JV partner, Shore Suven Pharma, Inc. Following the deal’s announceme...
The companies are planning for a reverse merger which would end the Memphis operations of GTx The merger will create a publicly trade...
The drug is aimed at patients with severe depression who have shown resistance to two antidepressants they have tried. The U.S. Food & Drug Administration (FDA)...
© 2021 itresearchbrief.com. All Rights Reserved.